Drug Safety Labeling Changes - March 2012

Creator: Madhumathi Palaniappan
Keywords: FDA label changes March - 2012, Drug Name, Sections Modified, Contraindications, Precautions, Adverse Reactions

Written & Compiled by - Madhumathi Palaniappan

Medically Reviewed by - The Medindia Medical Review Team

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

C - Contraindications
W - Warnings
P - Precautions
AR - Adverse Reactions

Drug Name	Sections Modified
Drug Name	C	W	P	AR
Abacavir	-	-	-	-
Amphotericin B	-	-
Atazanavir	-			-
Azithromycin	-			-
Belimumab	-
Bimatoprost	-	-	-
Candesartan cilexetil hydrochlorothiazide	-			-
Citalopram	-			-
Darifenacin	-			-
Desvenlafaxine	-	-	-
Ertapenem	-	-	-
Furosemide	-	-	-
Gadobenate- Dimeglumine	-
Galantamine	-	-	-	-
Itraconazole
Ketamine	-	-	-
Latanoprost	-	-	-
Lenalidomide	-			-
Lidocaine	-		-
Lisinopril	-			-
Meloxicam	-	-		-
Mitoxantrone	-	-	-	-
Naratriptan	-	-		-
Octreotide	-	-	-
Olmesartan	-			-
Oxybutynin Hydrochloride	-	-	-
Pazopanib	-
Repaglinide	-	-		-
Repaglinide and Metformin	-	-		-
Saxagliptin and Metformin	-			-
Sitagliptin	-			-
Sitagliptin-Metformin	-			-
Sumatriptan	-	-		-
Sumatriptan Succinate and Naproxen Sodium	-		-	-
Telaprevir	-			-
Telmisartan and Amlodipine	-			-
Zestoretic (lisinopril/hydrochlorothiazide) Tablets	-			-
Zoledronic Acid	-